EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrative Analysis of Glycine, Serine, and Threonine Metabolism and the Immune Microenvironment in Endometrial Cancer: A Prognostic Model and Metabolic-Immune Framework for Precision Oncology

Jingxuan Ye, Yashi Shi, Xite Lin, Maotong Zhang, Xiaodan Mao, Pengming Sun

Frontiers in Bioscience-Landmark · 2026

DOI: 10.31083/fbl48779 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2026. Verfasst von Jingxuan Ye und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, 350001 Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Tumor Microenvironment, Glycine, Serine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Province Central Government-Guided Local Science and Technology Development Project, Fujian Province health medicine innovation project, Joint Fundsfor the Innovation of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolic reprogramming is a hallmark of the pathogenesis and progression of endometrial carcinoma (EC). This study comprehensively analyzed the expression profiles of glycine, serine, and threonine (Gly/Ser/Thr) metabolism–related genes in EC. We also established a robust prognostic model and developed a molecular subtyping framework that integrates metabolic and immune characteristics based on the identified prognostic genes. The aims of this work are to enhance diagnostic precision and improve clinical management strategies for patients with EC.

Methods

Untargeted metabolomic analysis was performed on 35 EC and 15 normal tissues. The Cancer Genome Atlas (TCGA) transcriptomic data were integrated with weighted gene co-expression network analysis (WGCNA) to identify EC-related metabolic genes and construct a prognostic model using Cox proportional hazards and least absolute shrinkage and selection operator (LASSO) regression analyses. The model was validated using an independent proteomic and single-cell dataset from our institution. Consensus clustering classified patients into three molecular subtypes, which were further characterized by gene set variation analysis (GSVA) and profiling of immune infiltration. Finally, key prognostic genes were validated by reverse transcription quantitative polymerase chain reaction (RT-qPCR) in EC and normal endometrial epithelial cells.

Results

Metabolomic analysis revealed significant enrichment of the Gly/Ser/Thr metabolic pathways. WGCNA identified a tumor-associated metabolic module among 1741 pathway-related genes. A prognostic model comprising methylenetetrahydrofolate dehydrogenase 2 (MTHFD2), ribosomal protein S6 kinase A1 (RPS6KA1), and cyclin-dependent kinase inhibitor 2A (CDKN2A) was subsequently established. Consensus clustering based on risk scores stratified EC patients into three molecular subtypes: immunometabolic-suppressed (C1), proliferative-immunobalanced (C2), and immune-activated (C3). The C1 subtype had the poorest prognosis and was characterized by metabolic suppression and immune evasion. The C2 subtype showed a favorable prognosis and was defined by a “proliferation–immune balance” in which high proliferative activity coexisted with strong anti-tumor immunity. The C3 subtype was also associated with a favorable outcome, driven by upregulated DNA repair and oxidative phosphorylation pathways alongside infiltration of immune-active cells. RT-qPCR confirmed significant differences in the mRNA expression of MTHFD2, RPS6KA1, and CDKN2A between normal and EC cells (p < 0.05).

Conclusion

This study developed a Gly/Ser/Thr pathway–based prognostic model for EC, based on the expression of MTHFD2, RPS6KA1, and CDKN2A as novel biomarkers. The resulting patient stratification framework holds significant clinical potential for guiding precise and personalized management of EC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsTumor MicroenvironmentGlycineSerineThreonineFemaleHumansPrognosisPrecision MedicineMetabolic ReprogrammingGene Expression Regulation, NeoplasticMethylenetetrahydrofolate Dehydrogenase (NADP)Biomarkers, TumorMetabolomicsGene Expression ProfilingGlycine HydroxymethyltransferaseAminohydrolasesMultifunctional Enzymes

Stichwörter der Autor:innen

bioinformaticsbiomarkersendometrial cancermetabolic pathwaysprognosis

Substanzen

GlycineSerineThreonineMethylenetetrahydrofolate Dehydrogenase (NADP)Biomarkers, TumorMTHFD2 protein, humanGlycine HydroxymethyltransferaseAminohydrolasesMultifunctional Enzymes

Autor:innen und Institutionen

  • College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, 350001 Fuzhou, Fujian, China.
  • Laboratory of Gynecologic Oncology, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, 350001 Fuzhou, Fujian, China.
  • Fujian Key Laboratory of Women and Children's Critical Diseases Research, Fujian Maternity and Child Health Hospital (Fujian Women and Children's Hospital), 350001 Fuzhou, Fujian, China.
  • Fujian Clinical Research Center for Gynecological Oncology, Fujian Maternity and Child Health Hospital (Fujian Obstetrics and Gynecology Hospital), 350001 Fuzhou, Fujian, China.

Förderung

  • Fujian Province Central Government-Guided Local Science and Technology Development Project
  • Fujian Province health medicine innovation project
  • Joint Fundsfor the Innovation of Science and Technology
  • Fujian Provincial Nature Science Foundation of China
  • Fujian Province and the Startup Fund for scientific research, Fujian Medical University

Zitieren

APA

Ye, J., Shi, Y., Lin, X., Zhang, M., Mao, X., & Sun, P. (2026). Integrative Analysis of Glycine, Serine, and Threonine Metabolism and the Immune Microenvironment in Endometrial Cancer: A Prognostic Model and Metabolic-Immune Framework for Precision Oncology. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl48779

Vancouver

Ye J, Shi Y, Lin X, Zhang M, Mao X, Sun P. Integrative Analysis of Glycine, Serine, and Threonine Metabolism and the Immune Microenvironment in Endometrial Cancer: A Prognostic Model and Metabolic-Immune Framework for Precision Oncology. Frontiers in Bioscience-Landmark. 2026. doi:10.31083/fbl48779

BibTeX
@article{Ye2026,
  author = {Ye, Jingxuan and Shi, Yashi and Lin, Xite and Zhang, Maotong and Mao, Xiaodan and Sun, Pengming},
  title = {Integrative Analysis of Glycine, Serine, and Threonine Metabolism and the Immune Microenvironment in Endometrial Cancer: A Prognostic Model and Metabolic-Immune Framework for Precision Oncology},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  doi = {10.31083/fbl48779}
}
Kostenlos starten →